Guardant Health (FRA:5GH) Short Interest


FRA:5GH Guardant Health Inc FRA:5GH
67 GF Score
Price €124.64
GF Value €50.44
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Guardant Health Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

FRA:5GH vs LH, DGX, MEDP: Short Interest Comparison

For the Diagnostics & Research subindustry, Guardant Health's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Guardant Health Short Interest vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Guardant Health's Short Interest distribution charts can be found below:

* The bar in red indicates where Guardant Health's Short Interest falls into.


FRA:5GH
67GF Score
Guardant Health Inc FRA:5GH
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Guardant Health (FRA:5GH) Overvalued in 2026?

Based on GuruFocus' analysis, Guardant Health stock appears to be overvalued. The current stock price of €124.64 is trading 147.1% above its estimated GF Value™ of €50.44. GuruFocus considers Guardant Health to be Significantly Overvalued.

Key valuation signals for FRA:5GH:

  • Short Interest:
  • GF Value™: €50.44 vs. price of €124.64 (147.1% above fair value)
  • GF Score™: 67/100 with 4 warning signs

No single metric tells the full story. See the FRA:5GH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Guardant Health Business Description

Other Exchanges GH:USA1GH:Italy5GH:Germany
Address 3100 Hanover Street, Palo Alto, CA, USA, 94304
Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company's main franchises are Guardant360 for genomic profiling of tumors, Reveal for molecular residual disease testing, and Shield for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
67GF Score

Get the complete analysis for FRA:5GH

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€124.64
Price
€50.44
GF Value